Insufficient scRNA-seq data for expression of MT1L at single-cell level.
Insufficient scRNA-seq data for expression of MT1L at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 99% | 442.11 | 649 / 653 | 87% | 32.95 | 525 / 605 |
pancreas | 95% | 271.91 | 310 / 328 | 92% | 32.35 | 163 / 178 |
prostate | 99% | 420.40 | 242 / 245 | 87% | 53.84 | 435 / 502 |
kidney | 99% | 363.44 | 88 / 89 | 80% | 34.80 | 717 / 901 |
brain | 85% | 196.83 | 2251 / 2642 | 85% | 24.79 | 601 / 705 |
lung | 100% | 606.88 | 576 / 578 | 70% | 22.27 | 811 / 1155 |
adrenal gland | 100% | 474.01 | 257 / 258 | 64% | 19.99 | 148 / 230 |
liver | 100% | 1461.08 | 226 / 226 | 63% | 56.98 | 257 / 406 |
breast | 99% | 337.92 | 456 / 459 | 57% | 14.88 | 641 / 1118 |
stomach | 97% | 253.45 | 350 / 359 | 49% | 8.64 | 141 / 286 |
ovary | 72% | 100.03 | 129 / 180 | 72% | 17.01 | 309 / 430 |
bladder | 86% | 180.48 | 18 / 21 | 49% | 19.39 | 249 / 504 |
intestine | 81% | 132.00 | 787 / 966 | 51% | 10.43 | 270 / 527 |
uterus | 59% | 81.47 | 100 / 170 | 63% | 24.39 | 288 / 459 |
esophagus | 72% | 117.12 | 1038 / 1445 | 47% | 19.58 | 86 / 183 |
skin | 60% | 1283.43 | 1094 / 1809 | 45% | 33.20 | 214 / 472 |
adipose | 99% | 494.98 | 1195 / 1204 | 0% | 0 | 0 / 0 |
heart | 98% | 476.80 | 847 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 97% | 230.36 | 1298 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 83% | 18.07 | 24 / 29 |
spleen | 66% | 72.12 | 159 / 241 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 51% | 7.98 | 41 / 80 |
tonsil | 0% | 0 | 0 / 0 | 40% | 12.70 | 18 / 45 |
muscle | 26% | 37.97 | 209 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 12% | 24.09 | 109 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0071294 | Biological process | cellular response to zinc ion |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0071280 | Biological process | cellular response to copper ion |
GO_0010273 | Biological process | detoxification of copper ion |
GO_0045926 | Biological process | negative regulation of growth |
GO_0006882 | Biological process | intracellular zinc ion homeostasis |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0008270 | Molecular function | zinc ion binding |
GO_0046872 | Molecular function | metal ion binding |
Gene name | MT1L |
Protein name | Metallothionein-1L (MT-1L) (Metallothionein-IL) (MT-IL) |
Synonyms | |
Description | FUNCTION: Metallothioneins have a high content of cysteine residues that bind various heavy metals; these proteins are transcriptionally regulated by both heavy metals and glucocorticoids. . |
Accessions | Q93083 |